Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.940
-0.110 (-3.61%)
At close: Jul 31, 2026, 4:00 PM EDT
2.950
+0.010 (0.34%)
After-hours: Jul 31, 2026, 7:34 PM EDT
Genelux Market Cap
Genelux has a market cap or net worth of $130.56 million as of July 31, 2026. Its market cap has decreased by -0.91% in one year.
Market Cap
130.56M
Enterprise Value
106.85M
1-Year Change
-0.91%
Ranking
Category
Stock Price
$2.94
ChartMarket Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $130.56M, a decrease of -7.86%. That is a compound annual growth rate of -2.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 130.56M | -20.40% |
| Dec 31, 2025 | 164.02M | 103.78% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entera Bio | 145.41M |
| Unicycive Therapeutics | 145.18M |
| Canton Strategic Holdings | 142.68M |
| Aardvark Therapeutics | 139.62M |
| TuHURA Biosciences | 138.19M |
| Codexis | 134.53M |
| ProMIS Neurosciences | 133.80M |
| Connect Biopharma Holdings | 131.59M |